Accessibility Menu
PharmaCielo logo

PharmaCielo

(TSXV) PCLO

Current PriceCA$0.11
Market CapCA$17.86M
Since IPO (2019)-98%
5 Year-94%
1 Year+90%
1 Month+73%

PharmaCielo Financials at a Glance

Market Cap

CA$17.86M

Revenue (TTM)

CA$2.61M

Net Income (TTM)

-CA$4.55M

EPS (TTM)

-CA$0.03

P/E Ratio

-3.78

Dividend

CA$0.00

Beta (Volatility)

0.18 (Low)

Price

CA$0.11

Volume

100,899

Open

CA$0.09

Previous Close

CA$0.11

Daily Range

CA$0.08 - CA$0.11

52-Week Range

CA$0.04 - CA$0.17

Estimated Earnings Date

Jun 8, 2026

PCLO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PharmaCielo

Industry

Pharmaceuticals

CEO

Marc Lustig, MBA

Headquarters

Toronto, ON M5C 1P1, CA

PCLO Financials

Key Financial Metrics (TTM)

Gross Margin

29%

Operating Margin

-1%

Net Income Margin

-2%

Return on Equity

0%

Return on Capital

25%

Return on Assets

-53%

Earnings Yield

-26.46%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$17.86M

Shares Outstanding

187.98M

Volume

100.90K

Avg. Volume

57.64K

Financials (TTM)

Gross Profit

CA$756.41K

Operating Income

-CA$3.82M

EBITDA

-CA$1.00M

Operating Cash Flow

-CA$1.02M

Capital Expenditure

CA$12.00

Free Cash Flow

-CA$1.02M

Cash & ST Invst.

CA$289.24K

Total Debt

CA$18.65M

PharmaCielo Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

CA$606.15K

-46.2%

Gross Profit

CA$1.00M

+107.1%

Gross Margin

1.65%

N/A

Market Cap

CA$17.86M

N/A

Market Cap/Employee

CA$66.64K

N/A

Employees

268

N/A

Net Income

CA$407.41K

+127.1%

EBITDA

CA$869.14K

+305.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

-CA$18.36M

+9.9%

Accounts Receivable

CA$619.25K

+3.6%

Inventory

CA$1.72M

+14.2%

Long Term Debt

CA$0.00

-100.0%

Short Term Debt

CA$18.65M

+17.7%

Return on Assets

-53.17%

N/A

Return on Invested Capital

24.90%

N/A

Free Cash Flow

CA$530.75K

+235.5%

Operating Cash Flow

CA$530.75K

+235.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KHRN.VKhiron Life Sciences Corp.
CA$0.04+0.00%
VIVO.TOVIVO Cannabis Inc.
CA$0.03+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SUNESUNation Energy
$5.88+4.20%
INHDInno
$39.49+36.61%
NOKNokia
$14.59+0.01%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$41.26-0.04%

Questions About PCLO

What is the current price of PharmaCielo?

PharmaCielo is trading at CA$0.11 per share.

What is the 52-week range for PharmaCielo?

Over the past 52 weeks, PharmaCielo has traded between CA$0.04 and CA$0.17.

How much debt does PharmaCielo have?

As of the most recent reporting period, PharmaCielo reported total debt of CA$18.65M.

How much cash does PharmaCielo have on hand?

PharmaCielo reported CA$289.24K in cash and cash equivalents in its most recent financial results.

What is PharmaCielo’s dividend yield?

PharmaCielo does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.